0001127602-20-009831.txt : 20200306
0001127602-20-009831.hdr.sgml : 20200306
20200306162605
ACCESSION NUMBER: 0001127602-20-009831
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200304
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACKAY GEOFFREY
CENTRAL INDEX KEY: 0001741849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38537
FILM NUMBER: 20695089
MAIL ADDRESS:
STREET 1: C/O AVROBIO, INC.
STREET 2: ONE KENDALL SQ, BLDG. 300, STE. 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVROBIO, Inc.
CENTRAL INDEX KEY: 0001681087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810710585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7819626030
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AvroBio, Inc.
DATE OF NAME CHANGE: 20160729
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-03-04
0001681087
AVROBIO, Inc.
AVRO
0001741849
MACKAY GEOFFREY
C/O AVROBIO, INC.
ONE KENDALL SQUARE, BLDG. 300, SUITE 201
CAMBRIDGE
MA
02139
1
1
President & CEO
Stock Option (Right to Buy)
21.44
2020-03-04
4
A
0
292300
0
A
2030-03-03
Common Stock
292300
292300
D
25% of the shares shall vest and become exercisable on March 4, 2021, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.
/s/ Steven N. Avruch, Attorney-in-Fact for Geoffrey MacKay
2020-03-06